Latest FDA Stories
Growth Capital Allows Alimera to Fulfill Its Milestone Obligation Triggered by FDA Approval of ILUVIEN® ATLANTA, Sept. 30, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
CLEVELAND, Sept. 30, 2014 /PRNewswire/ -- Synapse Biomedical Inc.
SAN JOSE, Calif., Sept.
UPMC’s Decision Follows FDA Alert Discouraging Use of Power Morcellators in Uterine Surgeries, Morcellator Recall by Johnson & Johnson Chicago IL (PRWEB)
On September 24, The Original Soupman announced the recall of certain lots of its “Lobster Bisque” due to allergy alert.
When just one wrong word can derail an entire drug marketing campaign, manufacturers need to know what that one word is.
Since the high profile lawsuits for some metal-on-metal bearings, public outcry has prompted the FDA to heavily scrutinize new implant technology, reports iData Research. Vancouver,
EtQ, a leading provider of FDA Compliance, Quality Management and EHS Management software, today announced it will be presenting a live webinar hosted by Pharmaceutical Technology titled, “The
In May, the website for mesothelioma patients and their families reported on the first mesothelioma patient accepted into a U.K.
PRINCETON N.J., Sept. 29, 2014 /PRNewswire/ -- Guerbet, a pioneer in the field of contrast agents for medical imaging, has received a Drug Shortage Assistance Award from the U.S.
- Pertaining to the surface or end opposite to the mouth in a radiate animal.